Abiopharma

🔍 Topline Capital Management, LLC (Executive)

Company: NERDWALLET, INC. (NRDS)

Report Date: 2026-06-26

Detailed Transactions and Holdings:

• Sold 919,153 shares of Common Stock at $8.95 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,331,992.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 587,835 shares of Common Stock at $9.22 per share (Direct)
  Date: 2026-06-29 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,744,157.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 454,872 shares of Common Stock at $9.27 per share (Direct)
  Date: 2026-06-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,289,285.00 | transaction_form_type: 4 | Footnotes: F1, F3

Footnotes:

• F1: The reporting persons are (i) Topline Capital Management, LLC, a registered investment adviser (TCM) and (ii) Collin McBirney, TCMs managing member
• F2: Each reporting person may be deemed to beneficially own more than 10% of the issuers outstanding shares of common stock. Each reporting person disclaims beneficial ownership of the shares of common stock reported herein except to the extent of its or his pecuniary interest therein, and this report shall not be deemed to be an admission that any reporting person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose.
• F3: The shares of common stock reported in Table I on this Form 4 are beneficially owned by Topline Capital Partners, LP, a Delaware limited partnership (the Fund). As a greater than 10% beneficial owner, the Fund is separately reporting its holdings in the issuers securities on a Form 4 filed concurrently herewith. Each of TCM, as the investment manager and general partner of the Fund, and Mr. McBirney, as managing member of TCM, may be deemed to be the beneficial owner of the shares of common stock beneficially owned by the Fund.